Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

Author： Peterson Kim   McDonagh Marian   Fu Rongwei  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.197, Iss.1, 2008-03, pp. : 1-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Impact of Medications on Quality of Life in Attention-Deficit Hyperactivity Disorder: A Systematic Review

By Coghill David  

CNS Drugs, Vol. 24, Iss. 10, 2010-10 ,pp. : 843-866

Adis International

Access to resources Recommend Favorite

Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder: A Meta-Regression Analysis

By Castells Xavier   >   Rigau David  

CNS Drugs, Vol. 25, Iss. 2, 2011-02 ,pp. : 157-169

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: A Systematic Literature Review

By Wu Eric Q.  

CNS Drugs, Vol. 26, Iss. 7, 2012-07 ,pp. : 581-600

Adis International

Access to resources Recommend Favorite

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

By Wilens T.E.  

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2395-2411

Adis International

Access to resources Recommend Favorite

Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder

By Simpson D.   Plosker G.L.  

CNS Drugs, Vol. 18, Iss. 6, 2004-01 ,pp. : 397-401

Adis International

Access to resources Recommend Favorite